Skip to the reference

Reference desk / Entry

Liraglutide

Also listed as: Saxenda

Read the scope first. Then use the note and questions to examine what the evidence can answer.

Scoped product status
Approved product
Evidence label
Randomized evidence
Status as of

Reference fields

References for these fields are listed together in Sources.

Product and use scope
Saxenda: weight management for eligible patients.
Route context
Subcutaneous injection.
Mechanism
Activates the GLP-1 receptor.
Evidence
Randomized trials.
Limitations
Check other products separately.
Safety
The label warns about severe gastrointestinal reactions.

A question worth making clear

Before placing results from two reports side by side, check whether their outcome labels refer to the same measurement. Compare the definition, unit, assessment point, and way individual observations are combined. If a familiar word stands for different measures, note the difference beside the results instead of silently treating them as interchangeable. Decide together what would need to match for the intended comparison to make sense. This exercise can reveal that the reports are answering different questions, even when their headings appear to promise an answer about the same outcome.

  1. Do both reports define the outcome in a way that measures the same thing?
  2. Which differences in units or assessment points would matter to our comparison?
  3. What would need to match before we could interpret these results together?

Sources

Each date below belongs to the supplied source record. The references support the entry as a group.